Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.

Abstract

ObjectivesThe World Health Organization (WHO) recommends screening HIV‐infected people for cryptococcal antigens to identify cryptococcosis, a major cause of AIDS‐related deaths. As the burden of cryptococcosis is unknown in South Africa's KwaZulu‐Natal province, we assessed the cryptococcal antigenuria prevalence among newly diagnosed HIV‐infected adults there.MethodsWe conducted a cross‐sectional study of newly diagnosed HIV‐infected adults who received voluntary HIV testing in an out‐patient clinic. Participants provided a urine specimen in a sterile container, and we performed testing with a WHO‐endorsed rapid cryptococcal antigen lateral flow assay (Immy Inc., Norman, OK, USA) per the manufacturer's specifications. We assessed cryptococcal antigenuria prevalence among participants with CD4 counts < 200 cells/μL, and stratified results by CD4 count categories.ResultsAmong 432 participants, the mean (± standard deviation) age was 36.1 ± 9.9 years and 172 (40%) were female. The overall estimated prevalence of cryptococcal antigenuria was 9.0% [95% confidence interval (CI) 6.5–12.1%]. CD4 counts were available for 319 participants (74%); the median CD4 count was 75 cells/μL [interquartile range (IQR) 34–129 cells/μL]. Participants with a negative cryptococcal antigenuria screening test had a median CD4 count of 79 cells/μL (IQR 36–129 cells/μL), while participants with a positive cryptococcal test had a median CD4 count of 41 cells/μL (IQR 10–112 cells/μL). The estimated prevalence of cryptococcal antigenuria among participants with CD4 counts < 50 cells/μL was 12.5% (95% CI 7.0–20.1%), which was significantly higher than that among participants with CD4 counts of 50–200 cells/μL (4.8%; 95% CI 2.3–8.7%).ConclusionsNearly 1 in 10 newly diagnosed HIV‐infected adults with CD4 counts < 200 cells/μL in KwaZulu‐Natal had evidence of cryptococcal antigenuria. Point‐of‐care CD4 count testing and cryptococcal antigen screening may rapidly identify cryptococcosis at the time of HIV diagnosis.